Titre : Virus maedi-visna

Virus maedi-visna : Questions médicales fréquentes

Termes MeSH sélectionnés :

Complement C4b-Binding Protein
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Virus maedi-visna : Questions médicales les plus fréquentes", "headline": "Virus maedi-visna : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Virus maedi-visna : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-20", "dateModified": "2025-04-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Virus maedi-visna" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Lentivirus ovins-caprins", "url": "https://questionsmedicales.fr/mesh/D017972", "about": { "@type": "MedicalCondition", "name": "Lentivirus ovins-caprins", "code": { "@type": "MedicalCode", "code": "D017972", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.820.650.589.600" } } }, "about": { "@type": "MedicalCondition", "name": "Virus maedi-visna", "alternateName": "Visna-maedi virus", "code": { "@type": "MedicalCode", "code": "D014790", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xujie Duan", "url": "https://questionsmedicales.fr/author/Xujie%20Duan", "affiliation": { "@type": "Organization", "name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China." } }, { "@type": "Person", "name": "Xiaona Shi", "url": "https://questionsmedicales.fr/author/Xiaona%20Shi", "affiliation": { "@type": "Organization", "name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China." } }, { "@type": "Person", "name": "Shuying Liu", "url": "https://questionsmedicales.fr/author/Shuying%20Liu", "affiliation": { "@type": "Organization", "name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China." } }, { "@type": "Person", "name": "Stefán R Jónsson", "url": "https://questionsmedicales.fr/author/Stef%C3%A1n%20R%20J%C3%B3nsson", "affiliation": { "@type": "Organization", "name": "Institute for Experimental Pathology, University of Iceland, Keldur, Reykjavik 112, Iceland." } }, { "@type": "Person", "name": "Yalçın Yaman", "url": "https://questionsmedicales.fr/author/Yal%C3%A7%C4%B1n%20Yaman", "affiliation": { "@type": "Organization", "name": "Siirt University Faculty of Veterinary Medicine, Department of Genetics, Siirt, Türkiye." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Phosphorylation-Assisted Luciferase Complementation Assay Designed to Monitor Kinase Activity and Kinase-Domain-Mediated Protein-Protein Binding.", "datePublished": "2023-10-03", "url": "https://questionsmedicales.fr/article/37834301", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms241914854" } }, { "@type": "ScholarlyArticle", "name": "Barley AGO4 proteins show overlapping functionality with distinct small RNA-binding properties in heterologous complementation.", "datePublished": "2024-03-13", "url": "https://questionsmedicales.fr/article/38480545", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00299-024-03177-z" } }, { "@type": "ScholarlyArticle", "name": "Identification of Mitofusin 1 and Complement Component 1q Subcomponent Binding Protein as Mitochondrial Targets in Systemic Lupus Erythematosus.", "datePublished": "2022-06-06", "url": "https://questionsmedicales.fr/article/35128841", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/art.42082" } }, { "@type": "ScholarlyArticle", "name": "Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients.", "datePublished": "2023-05-08", "url": "https://questionsmedicales.fr/article/37244049", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.prp.2023.154519" } }, { "@type": "ScholarlyArticle", "name": "Endogenous complement 1q binding protein (C1qbp) regulates mitochondrial permeability transition and post-myocardial infarction remodeling and dysfunction.", "datePublished": "2024-08-27", "url": "https://questionsmedicales.fr/article/39209214", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.yjmcc.2024.08.005" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Virus", "item": "https://questionsmedicales.fr/mesh/D014780" }, { "@type": "ListItem", "position": 3, "name": "Virus à ARN", "item": "https://questionsmedicales.fr/mesh/D012328" }, { "@type": "ListItem", "position": 4, "name": "Retroviridae", "item": "https://questionsmedicales.fr/mesh/D012190" }, { "@type": "ListItem", "position": 5, "name": "Lentivirus", "item": "https://questionsmedicales.fr/mesh/D016086" }, { "@type": "ListItem", "position": 6, "name": "Lentivirus ovins-caprins", "item": "https://questionsmedicales.fr/mesh/D017972" }, { "@type": "ListItem", "position": 7, "name": "Virus maedi-visna", "item": "https://questionsmedicales.fr/mesh/D014790" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Virus maedi-visna - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Virus maedi-visna", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Virus maedi-visna", "description": "Comment diagnostiquer une infection par le virus maedi-visna ?\nQuels tests sont utilisés pour le virus maedi-visna ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on diagnostiquer le virus chez les animaux asymptomatiques ?\nQuelle est l'importance du diagnostic précoce ?", "url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+C4b-Binding+Protein&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Virus maedi-visna", "description": "Quels sont les symptômes principaux du virus maedi-visna ?\nLes symptômes varient-ils selon l'âge des moutons ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes sont-ils toujours présents ?\nComment évoluent les symptômes au fil du temps ?", "url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+C4b-Binding+Protein&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Virus maedi-visna", "description": "Comment prévenir l'infection par le virus maedi-visna ?\nLes tests de dépistage sont-ils efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nLes animaux doivent-ils être vaccinés ?\nComment gérer les nouveaux animaux dans un troupeau ?", "url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+C4b-Binding+Protein&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Virus maedi-visna", "description": "Quel est le traitement principal pour le virus maedi-visna ?\nPeut-on utiliser des antiviraux contre ce virus ?\nComment gérer les animaux infectés ?\nY a-t-il des vaccins disponibles ?\nQuel rôle joue la nutrition dans le traitement ?", "url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+C4b-Binding+Protein&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Virus maedi-visna", "description": "Quelles complications peuvent survenir avec le virus maedi-visna ?\nLes complications sont-elles fréquentes ?\nComment les complications affectent-elles la production ?\nLes complications sont-elles réversibles ?\nQuel est le pronostic pour les animaux infectés ?", "url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+C4b-Binding+Protein&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Virus maedi-visna", "description": "Quels sont les facteurs de risque d'infection ?\nLe stress augmente-t-il le risque d'infection ?\nLes races de moutons sont-elles affectées différemment ?\nL'environnement joue-t-il un rôle dans l'infection ?\nLes pratiques d'élevage influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+C4b-Binding+Protein&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par le virus maedi-visna ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sérologiques et des analyses PCR pour détecter le virus." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le virus maedi-visna ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests ELISA et PCR sont couramment utilisés pour identifier le virus dans le sang." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes cliniques comme la pneumonie et l'encéphalite orientent le diagnostic." } }, { "@type": "Question", "name": "Peut-on diagnostiquer le virus chez les animaux asymptomatiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sérologiques peuvent détecter le virus même sans symptômes visibles." } }, { "@type": "Question", "name": "Quelle est l'importance du diagnostic précoce ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic précoce permet de mieux gérer la maladie et de limiter sa propagation." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux du virus maedi-visna ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux, difficultés respiratoires et troubles neurologiques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge des moutons ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes animaux peuvent présenter des symptômes plus graves que les adultes." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des signes neurologiques comme des tremblements et des troubles de la coordination peuvent apparaître." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours présents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains animaux peuvent être porteurs sans montrer de symptômes cliniques." } }, { "@type": "Question", "name": "Comment évoluent les symptômes au fil du temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver progressivement, menant à des complications graves." } }, { "@type": "Question", "name": "Comment prévenir l'infection par le virus maedi-visna ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par l'isolement des animaux infectés et des pratiques d'élevage saines." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage régulier des troupeaux permet de détecter et d'éliminer les animaux infectés." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des mesures d'hygiène strictes, comme le nettoyage des équipements, sont essentielles." } }, { "@type": "Question", "name": "Les animaux doivent-ils être vaccinés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Bien qu'il n'y ait pas de vaccin, la vaccination contre d'autres maladies est recommandée." } }, { "@type": "Question", "name": "Comment gérer les nouveaux animaux dans un troupeau ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les nouveaux animaux doivent être testés et mis en quarantaine avant d'intégrer le troupeau." } }, { "@type": "Question", "name": "Quel est le traitement principal pour le virus maedi-visna ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement spécifique; la gestion des symptômes est essentielle." } }, { "@type": "Question", "name": "Peut-on utiliser des antiviraux contre ce virus ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'y a pas d'antiviraux efficaces spécifiquement pour le virus maedi-visna." } }, { "@type": "Question", "name": "Comment gérer les animaux infectés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les animaux infectés doivent être isolés et traités symptomatiquement pour améliorer leur confort." } }, { "@type": "Question", "name": "Y a-t-il des vaccins disponibles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de vaccin commercialement disponible contre le virus maedi-visna." } }, { "@type": "Question", "name": "Quel rôle joue la nutrition dans le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne nutrition peut aider à renforcer le système immunitaire des animaux infectés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le virus maedi-visna ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent pneumonie chronique et encéphalite, pouvant être mortelles." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications sont courantes chez les animaux infectés, surtout sans traitement." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la production ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la productivité des animaux, affectant la rentabilité de l'élevage." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais beaucoup sont irréversibles et graves." } }, { "@type": "Question", "name": "Quel est le pronostic pour les animaux infectés ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le pronostic dépend de la gravité des symptômes; beaucoup développent des complications graves." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'infection ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le stress, et la densité de population dans le troupeau." } }, { "@type": "Question", "name": "Le stress augmente-t-il le risque d'infection ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affaiblir le système immunitaire, augmentant le risque d'infection." } }, { "@type": "Question", "name": "Les races de moutons sont-elles affectées différemment ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines races peuvent être plus susceptibles à l'infection en raison de leur génétique." } }, { "@type": "Question", "name": "L'environnement joue-t-il un rôle dans l'infection ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un environnement surpeuplé et insalubre favorise la propagation du virus." } }, { "@type": "Question", "name": "Les pratiques d'élevage influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des pratiques d'élevage inadéquates augmentent le risque de transmission du virus." } } ] } ] }

Sources (10000 au total)

Phosphorylation-Assisted Luciferase Complementation Assay Designed to Monitor Kinase Activity and Kinase-Domain-Mediated Protein-Protein Binding.

Protein kinases are key regulators of cell signaling and have been important therapeutic targets for three decades. ATP-competitive drugs directly inhibit the activity of kinases but these enzymes wor...

Identification of Mitofusin 1 and Complement Component 1q Subcomponent Binding Protein as Mitochondrial Targets in Systemic Lupus Erythematosus.

Mitochondria are organelles that exhibit several bacterial features, such as a double-stranded genome with hypomethylated CpG islands, formylated proteins, and cardiolipin-containing membranes. In sys... Using shotgun proteomic profiling, we identified 1,345 proteins, 431 of which were associated with the mitochondrial proteome. Immunoreactivities to several of these candidate proteins were assessed i... We determined that IgG antibodies to the complement component C1q binding protein were significantly elevated in the patients with SLE (P = 0.049) and were also associated with lupus anticoagulant pos... In this study, we characterized the mitochondrial repertoire targeted by AMAs in the setting of SLE. Our results indicate that autoantibodies can recognize secreted and/or surface proteins of mitochon...

Proteomic analysis of small extracellular vesicles from the plasma of patients with hepatocellular carcinoma.

Liver cancer is one of the most common tumors with the seventh-highest incidence and the third-highest mortality. Many studies have shown that small extracellular vesicles (sEVs) play an important rol... We extracted sEVs from the plasma of controls and patients with HCC. Differentially expressed proteins in the sEVs were analyzed using label-free quantification and bioinformatic analyses. Western blo... Proteomic analysis was performed for plasma sEVs from 21 patients with HCC and 15 controls. Among the 335 identified proteins in our study, 27 were significantly dysregulated, including 13 upregulated... The complement cascade in sEVs was significantly involved in HCC progression. C1QB, C1QC, C4BPA, and C4BPB were highly abundant in the plasma sEVs from patients with HCC and might represent molecular ...

Complement Binding Anti-HLA Antibodies and the Survival of Kidney Transplantation.

Antibody-mediated rejection (AMR) is one of the most important challenges in the context of renal transplantation, because the binding of de novo donor-specific antibodies (dnDSA) to the kidney graft ... Our study included a cohort of 245 transplant patients over a 5-year period at Virgen de las Nieves University Hospital (HUVN) in Granada, Spain.... dnDSA was observed in 26 patients. Of these patients, 17 had non-complement-fixing dnDSA and 9 had complement-fixing dnDSA.... Our study demonstrated a significant association between the frequency of rejection and renal graft loss and the presence of C1q-binding dnDSA. Our results show the importance of the individualization...

Potential biomarkers of spinal dural arteriovenous fistula: C4BPA and C1QA.

A major challenge in spinal dural arteriovenous fistula (SDAVF) is timely diagnosis, but no specific predictive biomarkers are known.... In the discovery cohort (case, n = 8 vs. control, n = 8), we used cerebrospinal fluid (CSF) and paired plasma samples to identify differentially expressed proteins by label-free quantitative proteomic... In the discovery cohort, the most overexpressed proteins were APOB and C4BPA in CSF samples of patients. The GO/KEGG enrichment analysis indicated that the upregulated proteins were mainly involved in... This study was the first to identify C4BPA and C1QA as potential biomarkers for the diagnosis of SDAVF and revealed that complement pathway activation might be one of the molecular mechanisms for veno...

Alzheimer's disease-associated complement gene variants influence plasma complement protein levels.

Alzheimer's disease (AD) has been associated with immune dysregulation in biomarker and genome-wide association studies (GWAS). GWAS hits include the genes encoding complement regulators clusterin (CL... To address whether changes in plasma complement protein levels in AD relate to AD-associated complement gene variants we first measured relevant plasma complement proteins (clusterin, C1q, C1s, CR1, f... Complement dysregulation is evident in AD and may contribute to pathology. AD-associated SNPs in CR1, C1S and CFH impact plasma levels of the encoded proteins, suggesting a mechanism for impact on dis...